Persistent Membrane‐Anchored Oligomeric Peptides with Nanopore Formation for Targeted Immune Modulation
Angewandte Chemie International Edition · 27.10.2025 · 64 (44)
DOI: 10.1002/anie.202507700 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 11.09.2025. Verfasst von Jingtian Cao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medical Molecule Science and Pharmaceutics Engineering, Ministry of Industry and Information Technology, School of Chemistry and Ch…. Hauptthemen laut MEDLINE: Nanopores, Peptides, Cell Membrane. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing Natural Science Foundation, The Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
In the field of targeted diagnosis and therapy, one of the key challenges is the off‐target effect of these recognition molecules. Herein, a new class of oligomeric helical peptides is introduced through rational design and high‐throughput screening to address this challenge. Following amino acid mutations and structural optimizations, lead candidates TA03 and TA10 were identified. Thereinto, TA03 was shown to specifically recognize the PD‐L1 target and employ a unique aromatic side‐chain anchoring strategy to form stable nanopores on the tumor cell membrane, ensuring prolonged residence time. This structure from the precise match between helix length and lipid bilayer thickness, alongside the positioning of two tryptophan (Trp) residues near the peptide terminus. Both Trp side chains interact with the phospholipid membrane via aromatic‐hydrophobic forces, allowing TA03 to form an “hourglass‐like” pore structure. This design ensures proper membrane localization and extends residence time on tumor cells of TA03, increasing the persistent interactions between TA03 and PD‐L1, effectively avoiding off‐target effects. Furthermore, the unique structure and PD‐L1 targeting of TA03 cause physical disruption to tumor cells boosting immunotherapy effects and inhibiting tumor growth. It provides an avenue for new molecular structure to overcome off‐target effect towards the membrane associate targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Medical Molecule Science and Pharmaceutics Engineering, Ministry of Industry and Information Technology, School of Chemistry and Chemical Engineering, Tangshan Research Institute, Beijing Institute of…
- Zhengzhou Research Institute, Beijing Institute of Technology, Zhengzhou, 450000, P.R. China.
- School of Pharmaceutical Sciences and Food Engineering, Liaocheng University, 1 Hunan Street, Liaocheng, 252059, P.R. China.
ORCID-Profile: Weizhi Wang
Förderung
- National Natural Science Foundation of China
- Beijing Natural Science Foundation
- The Fundamental Research Funds for the Central Universities
- Natural Science Foundation of Hebei Province
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Cao, J., Yu, Y., Han, K., Wang, B., Ma, B., Zhang, L., Sun, B., Li, Y., Li, J., Ma, Y., Zhi, J., Zhao, J., & Wang, W. (2025). Persistent Membrane‐Anchored Oligomeric Peptides with Nanopore Formation for Targeted Immune Modulation. Angewandte Chemie International Edition, 64(44). https://doi.org/10.1002/anie.202507700
Vancouver
Cao J, Yu Y, Han K, Wang B, Ma B, Zhang L, et al. Persistent Membrane‐Anchored Oligomeric Peptides with Nanopore Formation for Targeted Immune Modulation. Angewandte Chemie International Edition. 2025;64(44). doi:10.1002/anie.202507700
BibTeX
@article{Cao2025,
author = {Cao, Jingtian and Yu, Yao and Han, Kai and Wang, Bo and Ma, Bokai and Zhang, Limin and Sun, Beilei and Li, Yongming and Li, Jiaqing and Ma, Yuning and Zhi, Junge and Zhao, Jinge and Wang, Weizhi},
title = {Persistent Membrane‐Anchored Oligomeric Peptides with Nanopore Formation for Targeted Immune Modulation},
journal = {Angewandte Chemie International Edition},
year = {2025},
volume = {64},
number = {44},
doi = {10.1002/anie.202507700}
}
EUVIMED